Wolfe Research Initiates Coverage On Zymeworks with Outperform Rating

Benzinga Newsdesk www.benzinga.com Positive 82.3%

Neg 0% Neu 0% Pos 82.3%

Wolfe Research analyst Kalpit Patel initiates coverage on Zymeworks (NASDAQ:ZYME) with a Outperform rating.

Comments

No comments yet. Be the first!